| HGNC Family | G protein-coupled receptors |
| Name | prostaglandin F receptor (FP) |
| Description | The protein encoded by this gene is member of the G-protein coupled receptor family. This protein is a receptor for prostaglandin F2-alpha (PGF2-alpha), which is known to be a potent luteolytic agent, and may also be involved in modulating intraocular pressure and smooth muscle contraction in uterus. Knockout studies in mice suggest that the interaction of PGF2-alpha with this receptor may initiate parturition in ovarian luteal cells and thus induce luteolysis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPTGFR, also known as the FP receptor, plays a central role in reproductive physiology. In animal models, signaling through this receptor in ovarian luteal cells is essential for initiating luteolysis and the subsequent decline in progesterone that triggers parturition. In human myometrium and decidua, exposure to proinflammatory cytokines such as interleukin‐1β upregulates PTGFR expression via NFκB‐dependent mechanisms, implicating FP receptor activity in uterine activation and labor ([."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn various cancers—most notably in endometrial adenocarcinomas—PTGFR expression is markedly elevated. FP receptor activation in these cells stimulates multiple mitogenic and proangiogenic signaling cascades, including trans‐activation of the epidermal growth factor receptor (EGFR), MAPK/ERK pathway phosphorylation, and NFAT‐dependent transcription. These events lead to increased cyclooxygenase‐2 expression, enhanced fibroblast growth factor (FGF) production, and altered cell cycle regulation that promote tumor cell proliferation and survival. Similar signaling also modulates melanocyte differentiation and pigment production. Together, these observations underscore a role for FP receptor signaling in driving tumorigenic processes ([."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPTGFR also contributes importantly to the regulation of vascular tone and renal function. In vascular smooth muscle cells, the FP receptor forms heterodimers with the angiotensin II type 1 receptor, an interaction that modulates vasoconstrictor responses and blood pressure. In the kidney, FP receptor expression in the cortical collecting ducts mediates a reduction in vasopressin‐stimulated water reabsorption, thereby influencing fluid balance ([."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}, {"type": "fg_fs", "start_ref": "16", "end_ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn ophthalmology, the FP receptor is the primary target of prostaglandin analogues such as latanoprost and bimatoprost, which are used to lower intraocular pressure in patients with glaucoma. Genetic polymorphisms in the PTGFR gene have been correlated with variable clinical responses to these drugs. Detailed pharmacological and structural analyses have elucidated receptor–ligand interactions and allosteric mechanisms that dictate drug efficacy, thereby aiding the optimization of glaucoma therapies ([."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in reproduction, tumorigenesis, and vascular regulation, FP receptor signaling intersects with numerous inflammatory and metabolic pathways. In human endometrial stromal cells, steroid withdrawal triggers reactive oxygen species (ROS)–induced NFκB activation that upregulates PGF₂α production, while in hepatocytes the receptor’s activation during fasting and diabetic stress enhances gluconeogenesis via a Ca²⁺/calmodulin– and CaMKII/p38/FOXO1–dependent cascade. Genetic studies have further implicated PTGFR variants in neuropsychiatric conditions, such as bipolar disorder, and in aspirin‐intolerant asthma, highlighting the receptor’s pleiotropic nature. Moreover, cross‐talk between FP and other prostanoid receptors modulates cyclic AMP dynamics in diverse cell types, including dental pulp cells and uterine smooth muscle ([."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nElevated systemic levels of PGF₂α, the endogenous ligand for FP receptor, have been associated with oxidative stress and increased platelet activation in hypertensive patients, suggesting that aberrant FP receptor signaling may contribute to vascular complications in such pathophysiological states ([."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent advances in structural biology have deepened our understanding of FP receptor function. Mutagenesis studies have identified critical residues for ligand binding and receptor activation, and cryo-electron microscopy has revealed unique conformational features and noncanonical activation motifs in FP receptor complexes. These structural insights illuminate mechanisms of biased signaling and provide a framework for the rational design of targeted therapeutics ([."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "32", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Y Sugimoto, A Yamasaki, E Segi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Failure of parturition in mice lacking the prostaglandin F receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (1997)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.277.5326.681"}], "href": "https://doi.org/10.1126/science.277.5326.681"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "9235889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/9235889"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Dean B Zaragoza, Robyn R Wilson, Bryan F Mitchell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The interleukin 1beta-induced expression of human prostaglandin F2alpha receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFkappaB."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Reprod (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1095/biolreprod.106.053439"}], "href": "https://doi.org/10.1095/biolreprod.106.053439"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16855208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16855208"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "S Makino, D B Zaragoza, B F Mitchell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decidual activation: abundance and localization of prostaglandin F2alpha receptor (FP) mRNA and protein and uterine activation proteins in human decidua at preterm birth and term birth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2006.06.010"}], "href": "https://doi.org/10.1016/j.placenta.2006.06.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16911823"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16911823"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ragner Liedman, Stefan Rocco Hansson, Sarah Igidbashian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myometrial oxytocin receptor mRNA concentrations at preterm and term delivery - the influence of external oxytocin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gynecol Endocrinol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/09513590802573213"}], "href": "https://doi.org/10.1080/09513590802573213"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19347709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19347709"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kurt J Sales, Stuart A Milne, Alistair R W Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2003-031434"}], "href": "https://doi.org/10.1210/jc.2003-031434"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14764825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14764825"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Kurt J Sales, Vivien Grant, Henry N Jabbour "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2008.01.016"}], "href": "https://doi.org/10.1016/j.mce.2008.01.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18316157"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18316157"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Glynis Scott, Stacey Jacobs, Sonya Leopardi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2004.11.016"}], "href": "https://doi.org/10.1016/j.yexcr.2004.11.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15748887"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15748887"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Kurt J Sales, David Maldonado-Pérez, Vivien Grant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2009.09.018"}], "href": "https://doi.org/10.1016/j.bbamcr.2009.09.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19819266"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19819266"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Eugénie Goupil, Dany Fillion, Stéphanie Clément, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.631119"}], "href": "https://doi.org/10.1074/jbc.M114.631119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25512374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25512374"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Kurt J Sales, Vivien Grant, Ian H Cook, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2010.090403"}], "href": "https://doi.org/10.2353/ajpath.2010.090403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20008143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20008143"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Kurt J Sales, Sheila C Boddy, Alistair R W Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2006-1517"}], "href": "https://doi.org/10.1210/en.2006-1517"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17478553"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17478553"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Andrea Pathe-Neuschäfer-Rube, Frank Neuschäfer-Rube, Gerhard P Püschel "}, {"type": "b", "children": [{"type": "t", "text": "Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20041321"}], "href": "https://doi.org/10.1042/BJ20041321"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15651980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15651980"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Tomomi Yoda, Kyoko Kikuchi, Yasuhiro Miki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2015.07.008"}], "href": "https://doi.org/10.1016/j.mce.2015.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26170067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26170067"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Kosuke Akiyama, Noritaka Ohga, Nako Maishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Int (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/pin.12031"}], "href": "https://doi.org/10.1111/pin.12031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23356224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23356224"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "X-B Chen, J W Regan "}, {"type": "b", "children": [{"type": "t", "text": "Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-005-5303-0"}], "href": "https://doi.org/10.1007/s00018-005-5303-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16378246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16378246"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Richard L Hébert, Monica Carmosino, Osamu Saito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M505852200"}], "href": "https://doi.org/10.1074/jbc.M505852200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16096282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16096282"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Rory Sleno, Dominic Devost, Darlaine Pétrin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.793877"}], "href": "https://doi.org/10.1074/jbc.M117.793877"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28584054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28584054"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Asim K Mandal, Rabindranath Ray, Zhongjian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Uteroglobin inhibits prostaglandin F2alpha receptor-mediated expression of genes critical for the production of pro-inflammatory lipid mediators."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M502375200"}], "href": "https://doi.org/10.1074/jbc.M502375200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16061484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16061484"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Y Liang, D F Woodward, V M Guzman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjp.2008.142"}], "href": "https://doi.org/10.1038/bjp.2008.142"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18587449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18587449"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Mayumi Sakurai, Tomomi Higashide, Mami Takahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ophthalmology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ophtha.2007.03.025"}], "href": "https://doi.org/10.1016/j.ophtha.2007.03.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17467803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17467803"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mayumi Sakurai, Tomomi Higashide, Shinji Ohkubo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between genetic polymorphisms of the prostaglandin F2α receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Ophthalmol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/bjophthalmol-2013-304267"}], "href": "https://doi.org/10.1136/bjophthalmol-2013-304267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24457363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24457363"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fernando Ussa, Itziar Fernandez, Maria Brion, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ophthalmology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ophtha.2014.12.038"}], "href": "https://doi.org/10.1016/j.ophtha.2014.12.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25704319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25704319"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Li-chen Gao, Di Wang, Fang-qun Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Clin Pharmacol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00228-014-1769-8"}], "href": "https://doi.org/10.1007/s00228-014-1769-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25339146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25339146"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Hoh Boon Peng, Mohd Nizam Zahary, Liza Sharmini Ahmad Tajudin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel single nucleotide polymorphism, IVS2 -97A>T, in the prostaglandin F2alpha receptor gene was identified among the Malaysian patients with glaucoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kobe J Med Sci (2007)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17582204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17582204"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "D T Chen, X Jiang, N Akula, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2011.157"}], "href": "https://doi.org/10.1038/mp.2011.157"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22182935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22182935"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Norihiro Sugino, Ayako Karube-Harada, Toshiaki Taketani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Reprod Dev (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1262/jrd.50.215"}], "href": "https://doi.org/10.1262/jrd.50.215"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15118249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15118249"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Sang-Heon Kim, Yoon-Keun Kim, Heung-Woo Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.fpc.0000239977.61841.fe"}], "href": "https://doi.org/10.1097/01.fpc.0000239977.61841.fe"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17496729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17496729"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Yuanyang Wang, Shuai Yan, Bing Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin F"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2α"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db17-1521"}], "href": "https://doi.org/10.2337/db17-1521"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29773555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29773555"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "M C Chang, Y J Chen, M Y Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin F(2alpha) stimulates MEK-ERK signalling but decreases the expression of alkaline phosphatase in dental pulp cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Endod J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2591.2010.01699.x"}], "href": "https://doi.org/10.1111/j.1365-2591.2010.01699.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20536573"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20536573"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "A B Abera, K J Sales, R D Catalano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2009.09.012"}], "href": "https://doi.org/10.1016/j.cellsig.2009.09.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19782748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19782748"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Maria Teresa Guagnano, Patrizia Ferroni, Francesca Santilli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Determinants of platelet activation in hypertensives with microalbuminuria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2009.01.005"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2009.01.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19280705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19280705"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Frank Neuschäfer-Rube, Eva Engemaier, Sina Koch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20021429"}], "href": "https://doi.org/10.1042/BJ20021429"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12519077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12519077"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Canrong Wu, Youwei Xu, Qian He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ligand-induced activation and G protein coupling of prostaglandin F"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2α"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-023-38411-x"}], "href": "https://doi.org/10.1038/s41467-023-38411-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37160891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37160891"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Xiaowen Xu, Binbin Wang, Yufan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Replicative verification of susceptibility genes previously identified from families with segregating developmental dysplasia of the hip."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ital J Pediatr (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13052-021-01087-4"}], "href": "https://doi.org/10.1186/s13052-021-01087-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34174923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34174923"}]}]}]}
|
| Synonyms | FP |
| Proteins | PF2R_HUMAN |
| NCBI Gene ID | 5737 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PTGFR has 6,015 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 118 datasets.
Click the + buttons to view associations for PTGFR from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PTGFR gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PTGFR gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PTGFR gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PTGFR gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving PTGFR protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGFR gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PTGFR gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PTGFR gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PTGFR gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PTGFR gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGFR gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PTGFR gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PTGFR gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PTGFR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PTGFR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of PTGFR gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PTGFR gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PTGFR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PTGFR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PTGFR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PTGFR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PTGFR gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PTGFR gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PTGFR gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PTGFR gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PTGFR gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for PTGFR protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with PTGFR gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PTGFR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PTGFR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PTGFR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PTGFR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PTGFR protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PTGFR gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PTGFR gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PTGFR gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PTGFR from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PTGFR gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PTGFR gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGFR gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PTGFR gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PTGFR from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PTGFR gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PTGFR gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PTGFR gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PTGFR gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PTGFR gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PTGFR gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PTGFR gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PTGFR gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PTGFR gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PTGFR protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PTGFR gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PTGFR gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PTGFR gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PTGFR gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PTGFR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PTGFR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding PTGFR receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with PTGFR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PTGFR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PTGFR gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PTGFR gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGFR gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PTGFR protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PTGFR gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PTGFR gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with PTGFR gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PTGFR gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PTGFR protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PTGFR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PTGFR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PTGFR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving PTGFR protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving PTGFR protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PTGFR gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PTGFR gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PTGFR gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PTGFR gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PTGFR protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PTGFR protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PTGFR gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PTGFR gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PTGFR gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PTGFR gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PTGFR gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PTGFR gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PTGFR from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PTGFR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PTGFR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PTGFR protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PTGFR protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving PTGFR protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PTGFR protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PTGFR gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of PTGFR gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PTGFR gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PTGFR gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PTGFR gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PTGFR gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PTGFR gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PTGFR gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PTGFR gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PTGFR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PTGFR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PTGFR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PTGFR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PTGFR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PTGFR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PTGFR protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PTGFR protein from the WikiPathways Pathways 2024 dataset. | |